Revolutionizing Clinical Trial Feasibility: Introducing TA Scan's Trial Feasibility Flex

By Elke Ydens, Associate Director, Business Solutions, Anju Software

Effective trial feasibility and enrollment planning are critical to the success of clinical research. However, the complex interplay of factors such as regulatory timelines, patient recruitment rates, site capacity, and competing trials often complicates the process. TA Scan’s Trial Feasibility Flex addresses these challenges by integrating robust global trial intelligence with user-specific insights to deliver precise, adaptable feasibility assessments. Trial Feasibility Flex enables researchers to customize critical inputs to generate predictive enrollment projections tailored to their study's unique needs. By leveraging advanced analytics this tool provides actionable insights for optimizing country and site selection, visualizing recruitment timelines, and anticipating challenges from competing trials.

In a real-world application for a phase 3 study targeting non-small cell lung cancer patients, Trial Feasibility Flex empowered the sponsor to develop realistic enrollment forecasts, prioritize recruitment efforts, and mitigate risks associated with site capacity and competitive overlap. This dynamic solution transforms feasibility into a continuous, data-driven process, helping sponsors streamline trial planning, maintain timelines, and deliver therapies to patients faster. Trial Feasibility Flex empowers researchers to adapt efficiently and achieve success in an evolving clinical landscape.